Dr. Luiza Caramori graduated top of her class from Medical School at the Universidade Federal do Rio Grande do Sul in Brazil and completed a residency in Internal Medicine followed by a clinical fellowship in pediatric and adult Endocrinology. She then completed a Masters in Science and subsequently obtained her PhD. Dr. Caramori was a research fellow in Pediatric Nephrology at the University of Minnesota (1998-2002), and a clinical fellow in Endocrinology and Diabetes (2004-2006). She joined the faculty at the University of Minnesota in 2006 and is an Associate Professor in the Department of Medicine and in the Department of Pediatrics. Dr. Caramori was the recipient of the prestigious JDRF Career Development Award and is the center PI on a NIH supported clinical trial evaluating the effects of allopurinol in preventing early renal function loss in diabetes. She is also the center PI for three other clinical trials in patients with diabetic kidney disease. Dr. Caramori is also the center PI for three other studies in diabetic kidney disease, one involving the study of kidney biopsy tissues in volunteers with early stage diabetic kidney disease. Dr. Caramori was also the PI on a JDRF grant evaluating epigenetic changes in diabetes and diabetic kidney disease and the Co-investigator on multiple NIH grants in the area of diabetes and its complications. She is nationally and internationally recognized by her research on diabetic kidney disease, the current chair of the American Diabetes Association diabetic nephropathy subcommittee and a member of the Kidney Disease: Improving Global Outcomes (KDIGO) task force.
Awards and recognition
- Masters Research Award, Brazilian Superior Education Development Agency (CAPES)
- PhD Research Award, Brazilian Superior Education Development Agency (CAPES)
- Post-Doctoral Fellowship Award, Juvenile Diabetes Research Foundation International
- Career Development Award, Juvenile Diabetes Research Foundation International